Financials

  • Market Capitalization 7.1 M
  • Employee 8
  • Founded 2017
  • CEO N/A
  • Website www.cnspharma.com
  • Headquarter Nevada, United States
  • FIGI BBG00PM24T16
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.1
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4887
IMRN
Immuron Limited - American Depositary Shares
1.24 USD+1.64%-4.62%+7.83%-36.41%7.25 M USD
4888
ADXN
Addex Therapeutics Ltd - American Depositary Shares
5.80 USD+1.58%-8.52%-7.50%-35.56%7.15 M USD
4892
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.65 USD+4.43%+13.79%+1.85%-14.06%7.09 M USD
4893
ERNA
Ernexa Therapeutics Inc. - Common Stock
6.06 USD+9.39%-5.75%+0.50%+1633.91%7.07 M USD

Notizie